Form EFFECT Lyra Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 26, 2026 |
| Accession Number: | 0001193125-26-124474 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LBank Exchange Listed GFO (GoodFundOne)
- Faraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: Provides Updates on Positive June Sales Targets; Recaps June 16 Robotics and Education Ecosystem Product Launch; Previews Ju
- Torex Semiconductor Has Achieved "Zero" Current Consumption with Multi-Function Load Switch ICs XC8115/XC8116 Series
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
